| Nam Soo Lee, MD | |
|
1726 Campbell Ave, Schenectady, NY 12306 | |
| (518) 372-6557 | |
| (518) 372-3472 |
| Full Name | Nam Soo Lee |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1726 Campbell Ave, Schenectady, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588624829 | NPI | - | NPPES |
| 0404260006727 | Other | FIDELIS | |
| 10002697 | Other | CDPHP | |
| 26103 | Other | MVP | |
| 76E58 | Other | EMPIRE BC | |
| 000401636001 | Other | BLUE SHIELD | |
| 00561477 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 133102 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nam Soo Lee, MD 1726 Campbell Ave, Schenectady, NY 12306 Ph: (518) 372-6557 | Nam Soo Lee, MD 1726 Campbell Ave, Schenectady, NY 12306 Ph: (518) 372-6557 |
News Archive
An Indian girl between the ages of one and five years old is 75 percent more likely to die than an Indian boy, giving the country the worst gender differential in child mortality in the world, according to new data released by the U.N. Department of Economic and Social Affairs, the Times of India reports.
Sheila Fleming, Ph.D., an assistant professor of pharmaceutical sciences at Northeast Ohio Medical University, was recently awarded a three-year, $954,566 grant by the U.S. Army Medical Research Acquisition Activity for the project titled, "Exercise Effects on Synuclein Aggregation, Neuroinflammation, and Neurodegeneration."
Eisai Inc., a subsidiary of Tokyo-based Eisai Co., Ltd., today announced the sale and assignment of its rights to a worldwide exclusive license for DACOGEN® (decitabine) for Injection to Otsuka Pharmaceutical Co., Ltd., giving Otsuka full development and commercialization rights for the product in the former Eisai territories of the United States, Canada and Japan.
A study at The University of Texas MD Anderson Cancer Center showed that circulating tumor cells, a form of liquid biopsy, was independently associated with melanoma relapse, suggesting CTC assessment may be useful in identifying patients at risk for relapse who could benefit from more aggressive therapy following primary treatment.
A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.
› Verified 3 days ago
Hadi Koohsari, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 Union St, Schenectady, NY 12305 Phone: 518-374-1610 Fax: 518-374-3512 | |
Dr. Michael Paul Sonnekalb, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3732 Carman Rd, Schenectady, NY 12303 Phone: 518-356-4132 Fax: 518-355-3996 | |
Stephanie B. Evans, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1044 State St, Schenectady, NY 12307 Phone: 518-370-1441 Fax: 518-395-9431 | |
Dr. James David Saperstone, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3732 Carman Rd, Schenectady, NY 12303 Phone: 518-356-4132 Fax: 518-355-3996 | |
Dr. Margaret M Woods, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Mcclellan St, Schenectady, NY 12304 Phone: 518-372-5637 Fax: 518-372-1384 | |
Dr. Richard Yan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Mcclellan St, Schenectady, NY 12304 Phone: 518-372-5637 Fax: 518-355-3996 | |
Kathleen Shanley, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3732 Carman Rd, Schenectady, NY 12303 Phone: 518-356-4132 |